DK332289A - Fremgangsmaade til diagnose af kronisk traethedssyndrom - Google Patents
Fremgangsmaade til diagnose af kronisk traethedssyndrom Download PDFInfo
- Publication number
- DK332289A DK332289A DK332289A DK332289A DK332289A DK 332289 A DK332289 A DK 332289A DK 332289 A DK332289 A DK 332289A DK 332289 A DK332289 A DK 332289A DK 332289 A DK332289 A DK 332289A
- Authority
- DK
- Denmark
- Prior art keywords
- syndrome
- chronic
- treaty
- diagnosis
- procedure
- Prior art date
Links
- 230000001684 chronic effect Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 abstract 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 abstract 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22076588A | 1988-07-07 | 1988-07-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK332289D0 DK332289D0 (da) | 1989-07-04 |
| DK332289A true DK332289A (da) | 1990-01-08 |
Family
ID=22824871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK332289A DK332289A (da) | 1988-07-07 | 1989-07-04 | Fremgangsmaade til diagnose af kronisk traethedssyndrom |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0350151B1 (de) |
| CN (1) | CN1056747C (de) |
| AT (1) | ATE103493T1 (de) |
| AU (2) | AU3781189A (de) |
| CA (1) | CA1336685C (de) |
| DE (1) | DE68914201T2 (de) |
| DK (1) | DK332289A (de) |
| ES (2) | ES2066847T3 (de) |
| IE (1) | IE63927B1 (de) |
| IL (1) | IL90875A (de) |
| NZ (1) | NZ229849A (de) |
| PT (1) | PT91094B (de) |
| ZA (1) | ZA895143B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0495831B1 (de) * | 1989-10-16 | 1997-01-15 | Hem Pharmaceuticals Corp. | Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion |
| GB9108085D0 (en) * | 1991-04-16 | 1991-06-05 | Scras | Complexes of polyadenylic acid with polyuridylic acid |
| US5776690A (en) * | 1996-10-07 | 1998-07-07 | Vojdani; Aristo | Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| CN101818145A (zh) | 1998-03-20 | 2010-09-01 | 联邦科学和工业研究组织 | 控制基因表达 |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| CA2361201A1 (en) | 1999-01-28 | 2000-08-03 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| CA2369944A1 (en) | 2001-01-31 | 2002-07-31 | Nucleonics Inc. | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
| US20120004290A1 (en) * | 2009-03-13 | 2012-01-05 | David Strayer | Treating chronic fatigue syndrome and prolonged qt interval |
| WO2019012159A1 (en) * | 2017-07-14 | 2019-01-17 | Protea Biopharma N.V. | METHODS AND MEANS FOR DIAGNOSING AND / OR TREATING A FATIGUE-ASSOCIATED DISEASE |
| KR20210104782A (ko) * | 2018-12-13 | 2021-08-25 | 에임 이뮤노테크 인코포레이티드 | 근통성뇌척수염 환자에서 운동 내구력을 개선시키는 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
| PH30882A (en) * | 1987-03-03 | 1997-12-23 | Hem Res Inc | Activated Rnase L as a maker for viral infections. |
| AU1820388A (en) * | 1987-07-17 | 1989-01-19 | Hem Research, Inc. | Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| EP0306347B1 (de) * | 1987-09-04 | 1995-05-10 | Hem Pharmaceuticals Corp. | Diagnose von Mangelzuständen doppelsträngiger RNS |
-
1989
- 1989-04-26 ES ES89304188T patent/ES2066847T3/es not_active Expired - Lifetime
- 1989-04-26 EP EP89304188A patent/EP0350151B1/de not_active Expired - Lifetime
- 1989-04-26 DE DE68914201T patent/DE68914201T2/de not_active Expired - Fee Related
- 1989-04-26 AT AT89304188T patent/ATE103493T1/de not_active IP Right Cessation
- 1989-06-30 CA CA000604511A patent/CA1336685C/en not_active Expired - Fee Related
- 1989-07-04 AU AU37811/89A patent/AU3781189A/en not_active Abandoned
- 1989-07-04 DK DK332289A patent/DK332289A/da not_active Application Discontinuation
- 1989-07-05 IL IL9087589A patent/IL90875A/en not_active IP Right Cessation
- 1989-07-06 ZA ZA895143A patent/ZA895143B/xx unknown
- 1989-07-06 IE IE218089A patent/IE63927B1/en not_active IP Right Cessation
- 1989-07-06 NZ NZ229849A patent/NZ229849A/en unknown
- 1989-07-06 ES ES8902387A patent/ES2018903A6/es not_active Expired - Fee Related
- 1989-07-07 CN CN89106706A patent/CN1056747C/zh not_active Expired - Fee Related
- 1989-07-07 PT PT91094A patent/PT91094B/pt not_active IP Right Cessation
-
1994
- 1994-08-02 AU AU68836/94A patent/AU684288B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NZ229849A (en) | 1997-07-27 |
| PT91094B (pt) | 1995-01-31 |
| DE68914201D1 (de) | 1994-05-05 |
| IE892180L (en) | 1990-01-07 |
| AU6883694A (en) | 1994-11-24 |
| ES2018903A6 (es) | 1991-05-16 |
| AU684288B2 (en) | 1997-12-11 |
| CN1056747C (zh) | 2000-09-27 |
| AU3781189A (en) | 1990-01-11 |
| CN1039722A (zh) | 1990-02-21 |
| PT91094A (pt) | 1990-02-08 |
| ES2066847T3 (es) | 1995-03-16 |
| ZA895143B (en) | 1991-04-24 |
| EP0350151A3 (en) | 1990-10-03 |
| IL90875A0 (en) | 1990-02-09 |
| IL90875A (en) | 1994-04-12 |
| CA1336685C (en) | 1995-08-15 |
| EP0350151A2 (de) | 1990-01-10 |
| DE68914201T2 (de) | 1994-07-14 |
| IE63927B1 (en) | 1995-06-28 |
| ATE103493T1 (de) | 1994-04-15 |
| DK332289D0 (da) | 1989-07-04 |
| EP0350151B1 (de) | 1994-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK332289A (da) | Fremgangsmaade til diagnose af kronisk traethedssyndrom | |
| Rosin et al. | Clinical features of accidental hypothermia, with some observations on thyroid function | |
| Watson et al. | Further development of a quality of life measure for cancer patients: the Rotterdam Symptom Checklist (revised) | |
| Cheong et al. | An epidemiological study of pityriasis rosea in Middle Road Hospital | |
| Dawson et al. | Diagnostic utility of autonomic measures for major depressive disorders | |
| Mitchell et al. | The pediatrician and hypertension | |
| Schirger et al. | Idiopathic orthostatic hypotension | |
| Borchgrevink | Cerebral processes underlying neuropsychological and neuromotor impairment in children with ADD/MBD | |
| Mathew et al. | Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients | |
| BR9007757A (pt) | Diagnostico e tratamento de disturbios neuro-cognitivos associados com disfuncoes imunologicas sistemicas | |
| Song et al. | Bilateral optic atrophy following diabetic ketoacidosis | |
| Llopis | THE AXIAL SYNDROME COMMON TO ALL PSYCHOSES: Part 2 | |
| Banov | Paroxysmal cold hemoglobinuria: Apparent remission after splenectomy | |
| Sato et al. | Characteristics of Sleep and Autonomic Activity in Active Older Adults Based on Metabolic Age: A Case Report | |
| Goudsouzian et al. | Histamine release from the administration of suxamethonium and atracurium in adolescents | |
| Sannerstedt et al. | Repeat hemodynamic studies in patients with arterial hypertension treated medically for several years | |
| Partonen et al. | Diagnostic assessment | |
| WOLF | Bulimia and the dexamethasone suppression test | |
| Poeck | Choreic Syndrome | |
| Karnad et al. | Diuretic treatment in decompensated cirrhosis and congestive heart failure: Effect of posture | |
| Padilla et al. | Human Responses to Cancer | |
| Kumagai et al. | A Case Report of Tomaculous Neuropathy (hereditary pressure sensitive neuropathy) | |
| King et al. | Da Costa's syndrome or neurocirculatory asthenia | |
| Parfitt | Water Excretion As A Measure Of Equilibrium With Environment | |
| Ellis | Clear thinking, electroencephalography, and brain death |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |